XML 64 R36.htm IDEA: XBRL DOCUMENT
v3.22.1

Compensation of Corporate Officers | 12 Months Ended
--- | ---
Dec. 31, 2021
Disclosure Of Compensation Of Corporate Officers [Abstract] |
Compensation of Corporate Officers | COMPENSATION OF CORPORATE OFFICERS On September 2, 2019, the Board of Directors accepted the resignation of the Chairman and Chief Executive Officer of the Company and decided to separate the roles of Chairman of the Board of Directors and Chief Executive Officer of Genfit SA with effect from September 16, 2019. At the same meeting, the Board of Directors appointed the Chief Executive Officer of the Company and confirmed the former Chairman and Chief Executive Officer in his functions as Chairman of the Board of Directors and member of certain committees of the Company's Board of Directors. Under these conditions, the following table details the compensation paid to the Chairman and Chief Executive Officer during the period from January 1, 2019 to September 16, 2019, and the compensation paid to the Chief Executive Officer in 2021, 2020 and during the period from September 16 to December 31, 2019 (after the change in governance) and the years in which the amounts were recognized in the statement of operations.
| Compensation paid to the Chairman |  | Year ended
| during the period from January 1, 2019 to September 16, 2019 |  |  |  |  |  |
| (in € thousands) |  | 2019/12/31 |  | 2020/12/31 |  | 2021/12/31
| Short-term employee benefits (gross + employer's social contributions, paid) |  | 1,338 |  |  | — |  |  | — |
| Post-employment pension & medical benefits |  | — |  |  | — |  |  | — |
| Share-based payment transactions |  | 109 |  |  | — |  |  | — |
| Director fees Genfit Corp (net) |  | 22 |  |  | — |  |  | — |
| TOTAL |  | 1,469 |  |  | — |  |  | — |
| Compensation paid to the Chief Executive Officer |  | Year ended
| (in € thousands) |  | 2019/12/31 |  | 2020/12/31 |  | 2021/12/31
| Short-term employee benefits (gross + employer's social contributions, paid) |  | 140 |  |  | 534 |  |  | 628 |
| Post-employment pension & medical benefits |  | — |  |  | — |  |  | — |
| Attendance fees |  | — |  |  | — |  |  | — |
| Share-based payment transactions |  | — |  |  | 41 |  |  | 58 |
| Director fees Genfit Corp (net) |  | — |  |  | — |  |  | — |
| TOTAL |  | 140 |  |  | 575 |  |  | 686 |
(1)Within this total, only the portion of the amounts paid in 2019 to the Chairman and Chief Executive Officer pursuant to the 13th resolution of the Annual General Meeting of June 13, 2019, for the part of the Incentive Plan corresponding to that portion of work on the initial public offering of the Company on the Nasdaq Global Select Market carried out in 2018, i.e., ¾ of the amount due, i.e. a gross amount of €562,893. However, the Chairman of the Board of Directors decided to forgo the balance amount of €187,631, which had been recorded in 2019. The Chief Executive Officer’s corporate contract contains a clause whereby, in the event of termination, he would receive a non-compete indemnity equal to: (i)twelve (12) months of fixed compensation, calculated on the basis of the gross amounts due for the past twelve months ended and (ii)increased, where applicable, by the amount of the annual variable compensation due for the previous year. This compensation is intended to compensate the prohibition made to the Chief Executive Officer, for a period of 12 months following the termination of his functions, for whatever reason, to work in any way whatsoever with certain companies carrying out a directly competitive activity of the Company. In addition, the Chief Executive Officer, except in the event of gross negligence within the meaning of labor law, shall receive severance pay equal to: (i)twelve (12) months of fixed compensation, calculated on the basis of the gross amounts due for the twelve past completed months and (ii)increased, where applicable, by the amount of annual variable compensation due for the previous year. This compensation will be paid one month after his effective termination of activity within the Group. The compensation will not be paid if, on his initiative, the Chief Executive Officer leaves the Company to exercise new functions or changes functions within the Group, or even if he has the possibility of asserting in the short term his retirement rights. It is also specified that any sum paid under the non-competition clause will be deducted from the sums due under the severance pay and vice versa. The total and maximum commitment represented by this indemnity (gross, employer charges and payroll tax) as of December 31, 2021 would amount to €523. The Chairman of the Board of Directors, Jean-François Mouney, receives a fixed compensation. He also has use of a company vehicle and the Group’s insurance and disability plan. These benefits are totaled in the table below in the "Other remuneration" line. The Chairman of the Board of Directors also receives attendance fees granted for his participation in the work of some of the committees of the Board of Directors. The directors' fees and other compensation due and paid to the non executive directors are as follows:
|  |  | Amounts due* |  | Amounts paid* |  | Amounts due* |  | Amounts paid* |  | Amounts due* |  | Amounts paid*
| Attendance fees and other forms of remuneration payable to each of the non executive officer |  | During the year ended December 31,
| (in euros) |  | 2019 |  | 2020 |  | 2021
| Jean-François MOUNEY (1) |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 14,791 |  |  | 633 |  |  | 49,937 |  |  | 49,939 |  |  | 45,863 |  |  | 39,232 |
| Other remuneration |  | 88,874 |  |  | 88,874 |  |  | 286,469 |  |  | 286,469 |  |  | 286,553 |  |  | 286,553 |
| TOTAL |  | 103,665 |  |  | 89,507 |  |  | 336,406 |  |  | 336,408 |  |  | 332,416 |  |  | 325,785 |
| Xavier GUILLE DES BUTTES |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 68,016 |  |  | 67,580 |  |  | 85,020 |  |  | 80,660 |  |  | 89,822 |  |  | 85,020 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | 68,016 |  |  | 67,580 |  |  | 85,020 |  |  | 80,660 |  |  | 89,822 |  |  | 85,020 |
| Frédéric DESDOUITS |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 33,136 |  |  | 30,302 |  |  | 53,360 |  |  | 44,640 |  |  | 43,600 |  |  | 47,960 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | 33,136 |  |  | 30,302 |  |  | 53,360 |  |  | 44,640 |  |  | 43,600 |  |  | 47,960 |
| BIOTECH AVENIR |  |  |  |  |  |  |  |  |  |  |  |
| Représenté par Florence Séjourné |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| Philippe MOONS |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 36,188 |  |  | 41,202 |  |  | 45,780 |  |  | 41,420 |  |  | 16,986 |  |  | 25,161 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | 36,188 |  |  | 41,202 |  |  | 45,780 |  |  | 41,420 |  |  | 16,986 |  |  | 25,161 |
| Anne-Hélène MONSELLATO |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 44,472 |  |  | 53,410 |  |  | 50,140 |  |  | 45,780 |  |  | 52,320 |  |  | 52,320 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | 44,472 |  |  | 53,410 |  |  | 50,140 |  |  | 45,780 |  |  | 52,320 |  |  | 52,320 |
| Catherine LARUE |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | 33,136 |  |  | 28,122 |  |  | 43,600 |  |  | 43,600 |  |  | 47,651 |  |  | 45,780 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | 33,136 |  |  | 28,122 |  |  | 43,600 |  |  | 43,600 |  |  | 47,651 |  |  | 45,780 |
| Katherine KALIN |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | — |  |  | — |  |  | 15,805 |  |  | 4,360 |  |  | 43,600 |  |  | 39,240 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | — |  |  | — |  |  | 15,805 |  |  | 4,360 |  |  | 43,600 |  |  | 39,240 |
| Eric BACLET |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | — |  |  | — |  |  | 20,165 |  |  | 6,540 |  |  | 62,881 |  |  | 62,336 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | — |  |  | — |  |  | 20,165 |  |  | 6,540 |  |  | 62,881 |  |  | 62,336 |
| Jean-François TINE |  |  |  |  |  |  |  |  |  |  |  |
| Attendance fees |  | — |  |  | — |  |  | — |  |  | — |  |  | 39,724 |  |  | 23,919 |
| Other remuneration |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
| TOTAL |  | — |  |  | — |  |  | — |  |  | — |  |  | 39,724 |  |  | 23,919 |
| TOTAL |  | 318,613 |  |  | 310,123 |  |  | 650,276 |  |  | 603,408 |  |  | 729,000 |  |  | 707,521 |
(1) The attendance fees and other remuneration for Jean-François Mouney above correspond to amounts due for the period from September 16, 2019 to December 31, 2019 and the full year 2020 and 2021. In addition, the Company has provided corporate officers, directors and members of the Executive Committee a “directors and officers” insurance against claims relating to certain actions they may take in the performance of their duties. For the 12 months of the calendar year 2021, the insurance premium for the implementation of this insurance coverage amounted to €2,052 (€1,316 in 2020 and €3,146 in 2019)

X
- Definition Disclosure of compensation of corporate officers. + References No definition available. + Details
Name: | gnft_DisclosureOfCompensationOfCorporateOfficersAbstract
Namespace Prefix: | gnft_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of compensation of corporate officers. + References No definition available. + Details
Name: | gnft_DisclosureOfCompensationOfCorporateOfficersExplanatoryTextBlock
Namespace Prefix: | gnft_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration